GlobeNewswire

Olainfarm Group’s financial performance in the first half reached new highs – sales were 66.4 million EUR; net profit jumps to 12.2 million EUR

Share
  • Group sales in the first half 2019 were 66.4 million EUR, which is 7% higher than a year earlier
  • EBITDA margin for the first six month 2019 was 26%, up from 17% year ago
  • Strong liquidity and decrease in leverage support further investment needs

“Looking at the six months of Olainfarm’s financial year and its good financial position, three things should be noted: 1) the high profitability of the company; 2) a significant increase in the company’s liquidity to historically high levels; and 3) active negotiations with banks and to provide new loans. These are also key factors that provide a solid foundation for a new development stage for organising drug dossiers and conducting clinical trials for medicines,” says Lauris Macijevskis, Chairman of the Management Board of JSC Olainfarm.

During the 2nd quarter of 2019, consolidated sales of the Olainfarm Group reached 31 647 thousand EUR which is an increase by 592 thousand EUR euros or 2% if compared to similar period of 2018. In the 2nd quarter EBITDA was 6 422 thousand EUR that surpassed the figure of the 2nd quarter of 2018 by 1 497 thousand EUR or 30%. Profit for this year’s second quarter was 3 984 thousand EUR, which is an increase by 49% or 1 312 thousand EUR in comparison with the second quarter of 2018.

During the first six months of this year Group’s sales reached 66 392 thousand EUR, which is an increase by 7% or 4 548 thousand EUR comparing to the same period of 2018. Group’s EBITDA during this year’s first six months was 16 928 thousand EUR, which is by 64% or 6 589 thousand EUR more than the half year results of the last year. Group’s reporting period profit for the six month 2019 was 12 244 thousand EUR and it increased by 112% or 6 458 thousand EUR in comparison with half year of 2018. Half-year 2019 sales, EBITDA and net profit mark new record levels for the first six months period.

Reporting period profit was positively influenced by gross margin increase, selling expense decrease, income from currency rate fluctuations but negatively impacted by increase of administrative expenses. Administrative expenses rose due to investments in medicine registration dossiers and such costs may not always be possible to capitalize as well as with review of salaries and bonus payments to personnel (excluding the Supervisory Council and the Management Board).

In accordance with the approved plans for 2019 Group’s sales target is fulfilled by 50% and profit figure by 96%.

During the first six months of this year sales volumes of the main Olainfarm products continued to increase. The share of the leading product Noofen is 19%, which is by one percentage point more than a year before. The share of the three largest products (Noofen, Neiromidin and Furamag/Furasol) comprise 52% that is by one percentage point higher than a year before (51%).

In April this year JSC Olainfarm signed agreement with a unit of UN (UN Office for Project Services) about deliveries of PASS in the amount of 3 million EUR during 2019-2020, which will keep this medicine among top products also in the future.

Group introduced two new alternative performance indicators - Net debt to EBITDA ratio and Debt – Service Coverage Ratio (DSCR). Net debt to EBITDA improved from 1.4 to 0.6 and DSCR from 1.8 to 2.5.

The first half of 2019 was also significant due to rapid improvements in cash position from 2 689 thousand EUR at the beginning of the year to 10 623 thousand EUR, which allows to continue investments in updating medicine dossiers in the coming years.

During the second quarter of 2019, more than 731 thousand shares of JSC Olainfarm, with total value of 4.5 million euros, were traded on Nasdaq Riga. Compared to the same period in 2018, the number of traded shares was by 726% more, while traded value was higher by 511%.

Consolidated statement of comprehensive income Group Group
  Q2 2019 Q2 2018 M6 2019 M6 2018
  EUR '000 EUR '000 EUR '000 EUR '000
Revenue   31 647   31 055   66 392   61 844
Cost of goods sold   (11 818)   (12 117)   (25 309)   (24 895)
Gross Profit   19 829   18 938   41 083   36 949
Selling expense        (8 740)   (9 510)      (17 021)   (18 181)
Administrative expense        (7 299)   (5 790)      (13 632)   (11 431)
Other operating income   672   687   1 134   1 405
Other operating expense           (449)   (1 093)           (704)   (1 804)
Share of profit of an associate   25   7   103   75
Financial income   279   19   1 842   39
Financial expense           (327)   (501)   (488)   (1 091)
Profit Before Tax   3 990   2 757   12 317   5 961
Corporate income tax               (5)   (87)             (72)   (177)
Deferred corporate income tax   (1)   2   (1)   2
PROFIT FOR THE REPORTING PERIOD   3 984   2 672   12 244   5 786
Other comprehensive income for the reporting period   62   41   217   36
Total comprehensive income for the reporting period   4 046   2 713   12 461   5 822
Total comprehensive income attributable to:        
The equity holders of the Parent Company   4 046   2 713   12 461   5 822
Non-controlling interests   -   -   -   -
         
Basic and diluted earnings per share, EUR   0.28   0.19   0.87   0.41


Condensed Consolidated Statement of  Financial Position Group
    30.06.2019 31.12.2018
    EUR '000 EUR '000
    ASSETS    
NON-CURRENT ASSETS    
Intangible assets   36 388   36 619
Property, plant and equipment   44 832   43 697
Right-of-use assets   7 230   -
Investment properties   3 510   3 492
Other non-current assets   868   983
  TOTAL NON-CURRENT ASSETS   92 828   84 791
CURRENT ASSETS    
Inventories   29 744   25 794
Receivables   29 785   34 637
Cash   10 623   2 689
  TOTAL CURRENT ASSETS   70 152   63 120
TOTAL ASSETS   162 980   147 911
     
    EQUITY AND LIABILITIES    
EQUITY    
Share capital   19 719   19 719
Share premium   2 504   2 504
Reserves   (7)   (224)
Retained earnings   93 914   83 079
  TOTAL EQUITY   116 130   105 078
LIABILITIES    
Non-current liabilities    
Borrowings and lease liabilities   6 590   1 793
Deferred income   3 418   2 878
  Total Non-Current Liabilities   10 008   4 671
Current liabilities    
Borrowings and lease liabilities   19 015   23 236
Trade payables and other liabilities   16 047   14 540
Dividends payable   1 409   -
Deferred income   371   386
  Total Current Liabilities   36 842   38 162
  TOTAL LIABILITIES   46 850   42 833
TOTAL EQUITY AND LIABILITIES   162 980   147 911

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Additional information:
       
Jānis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Ph.: +371 29178878
E-mail: janis.dubrovskis@olainfarm.com

Attachment

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

PRF: AS PRFoods’ unaudited preliminary consolidated turnover of the 4th quarter and 12 months of the 2019/2020 financial year12.7.2020 14:14:14 CESTPress release

PRFoods’ unaudited preliminary consolidated turnover in 4th quarter of the fiscal year 2019/2020 amounted to EUR 15.11 million euros, decreased by 29.5% compared to the same period a year ago (4Q 2018/2019: 21.42 million euros). The preliminary turnover of the first 12 months of the financial year was 78.34 million euros (12m 2018/2019: 85.61 million euros). The Q4 decline in sales was 29.5%; including sales increase in retail sector by 7.3%, sales decrease in HoReCa sector by 65.0% and in wholesale sector by 49.6% (partly also influenced by HoReCa sector) compared to the same period previous year; The 12-months sales decrease compared the same period a year ago was 8.5%, mainly affected by lower sales figure in the 4th quarter. During 2019/2020 the product portfolio experienced a change where raw fish and fillets’ segment increased by 4 pp and smoked products declined accordingly. Indrek Kasela, CEO, PRFoods : „Last quarter was defined by the fact that most countries took drastic meas

Volta Finance Limited: Net Asset Value as at 30 June 202010.7.2020 18:25:06 CESTPress release

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES ***** Guernsey, 10 July 2020 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for June. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com). PERFORMANCE and PORTFOLIO ACTIVITY June delivered another month of strong performance after May and April, helping further to recover the mark-to-market impact of the COVID-19 pandemic. Accounting for the €0.10 per share dividend paid 16th of June, Volta’s NAV* total return performance in June was +6.9%. With the increased confidence around cash flows from underlying assets over the medium term, not only was the Company able to restore the dividend ordinarily payable in April but has further declared a dividend of €0.11 per share payable on 29th July 2020, which is a return to the Company’s original payment timetable. The monthly perfo

Agfa-Gevaert: Publication of a transparency notification – Regulated information10.7.2020 17:40:00 CESTPress release

(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – July 10, 2020 - 5.40 p.m. CET According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%. In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Euronext: AGFB) discloses the following declaration: On July 3, 2020, Classic Fund Management AG has announced that as per July 1, 2020, its stake in Agfa-Gevaert is less than 3%. Notifications of important shareholdings to be made according to the Law of May 2, 2007 or Agfa-Gevaert NV’s bylaws, should be sent to viviane.dictus@agfa.com Contact: Viviane Dictus Director Corporate Communications tel. ++32 (0) 3 444 7124 e-mail: viviane.dictus@agfa.com Attachment 20200710 Classic Fund UK

Mandalay Resources Corporation meddelar sina produktions- och försäljningsresultat för andra kvartalet 202010.7.2020 15:17:47 CESTPressemelding

TORONTO, July 10, 2020 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) tillkännagav idag sina produktions- och försäljningsresultat för andra kvartalet 2020. Under andra kvartalet 2020 producerade Mandalay en konsoliderad mängd motsvarande 24 752 säljbara uns guldekvivalent och sålde 24 916 uns guldekvivalent. Mandalays President och Chief Executive Officer, Dominic Duffy förklarade, ”Båda verksamheterna har fortsatt sin starka start på året med förbättrade resultat från första till andra kvartalet vad gäller total mängd sålda uns guldekvivalent. Produktionsresultatet för andra kvartalet var bolagets bästa konsoliderade guldproduktion för ett enskilt kvartal sedan fjärde kvartalet 2017.” Duffy konstaterade vidare, ”Resultaten i Costerfield var fortsatt utmärkta från Youle-ådern, vars anläggning producerade 13 502 uns guldekvivalent. Antimonproduktionen hade ännu ett stabilt kvartal med 933 sålda ton, vilket var bolagets högsta mä

Volta Finance Limited : Director Declaration10.7.2020 15:09:22 CESTPress release

Volta FinanceLimited (VTA/VTAS) Director Resignation Guernsey, 10 July 2020 Volta Finance Limited (the “Company”) announces that Atosa Moini, a non-executive director of the Company and Chair of the Management Engagement Committee, has notified the Company of her intention to step down from her role on the Board and resign as a Director of the Company with effect from 31st July 2020. Ms Moini has been on the Board since 2017 and the Directors would like to express their gratitude to her for her valuable contribution during that period. For further information, please contact: Company Secretary and Administrator BNP Paribas Securities Services S.C.A, Guernsey Branch guernsey.bp2s.volta.cosec@bnpparibas.com +44 (0) 1481 750 853

Bergman & Beving AB: The Annual Report for 2019/2020 has been published10.7.2020 15:00:00 CESTPress release

Press release The Annual Report for 2019/2020 has been published Bergman & Beving’s Annual Report for the financial year 1 April 2019–31 March 2020 has been published on the company's website today where it can be downloaded as a PDF version. Stockholm, 10 July 2020 Bergman & Beving AB (publ) For further information, please contact: Peter Schön, CFO, phone no.: +46 70 339 89 99 This information is information that Bergman & Beving AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 3.00pm CET on 10 July 2020. Bergman & Beving owns and refines companies that develop and market strong brands for professional users in industry and construction, mainly in the Nordic region, the Baltic States and Poland. Bergman & Beving aims to enable successful product companies to take the next step and become leading brands in their categories. The Group currently has some 20 brands, about 1,000 employees and revenue of approximate